Invention Grant
US08350093B2 Methylated curcumin-resveratrol hybrid molecules for treating cancer
有权
用于治疗癌症的甲基化姜黄素 - 白藜芦醇混合分子
- Patent Title: Methylated curcumin-resveratrol hybrid molecules for treating cancer
- Patent Title (中): 用于治疗癌症的甲基化姜黄素 - 白藜芦醇混合分子
-
Application No.: US12779486Application Date: 2010-05-13
-
Publication No.: US08350093B2Publication Date: 2013-01-08
- Inventor: Thomas M. DiMauro
- Applicant: Thomas M. DiMauro
- Applicant Address: US MA Raynham
- Assignee: Codman & Shurtleff, Inc.
- Current Assignee: Codman & Shurtleff, Inc.
- Current Assignee Address: US MA Raynham
- Main IPC: C07C41/00
- IPC: C07C41/00 ; C07C43/02 ; C07C43/20 ; A01N31/14 ; A61K31/75
Abstract:
Methylated curcumin-methoxystilbene hybrid molecules that have particular use in treating cancer.
Public/Granted literature
- US20100292512A1 Methylated Curcumin-Resveratrol Hybrid Molecules for Treating Cancer Public/Granted day:2010-11-18
Information query
